BillionaireNet
Hamied
M
Rank #2822
INDIAHealthcarePharmaceuticals

Mustafa Hamied

Net Worth
$1.215B
+0.08% (24h)
Mustafa Hamied, the 85-year-old pharmaceuticals magnate, significantly impacted the healthcare sector. His primary source of wealth stems from his involvement in Cipla, a leading pharmaceutical company founded by his father. He served as non-executive vice chairman of Cipla until September 2024. Hamied's career reflects a commitment to making healthcare accessible and affordable, particularly through the development of generic drugs. He is the father of three children and has been married. His focus on quality, innovation, and ethical business practices has established Cipla as a global player, with a market cap of $13.42 Billion USD, while generating a revenue of $3.21 Billion USD. Hamied's legacy underscores the importance of philanthropy and ethical business conduct in the pharmaceutical industry.

The Full Dossier

Early Life

Mustafa Hamied was born on October 23, 1940, into a family with deep roots in healthcare and social service. His father, Khwaja Abdul Hamied, founded Cipla in 1935 with the aim of making essential medicines accessible to all. Mustafa inherited the business along with his older brother Yusuf after their father's death.

Rise to Success

Mustafa Hamied’s career at Cipla spanned 47 years. He played a key role in the expansion of Cipla into a global pharmaceutical company. He helped Cipla grow from a company with annual sales of Rs 48 lakh in 1960 to one of the leading pharmaceutical companies in India and abroad. His strategic decisions and leadership were instrumental in Cipla's growth, expanding its presence in India, South Africa, and North America, among other markets. Hamied was the non-executive vice chairman of Cipla until September 2024.

Key Business Strategies

Hamied's business approach focused on innovation and cost-effective solutions. Cipla, under his leadership, was recognized for manufacturing high-quality, affordable generic medicines, particularly for diseases such as HIV/AIDS. This strategy not only made medication accessible to underserved populations but also challenged the dominance of multinational drug companies.

Philanthropy

Mustafa Hamied is committed to philanthropy and social responsibility. He has championed initiatives to improve healthcare infrastructure and promote public health awareness.

Career Timeline

2024

Resigned as Vice Chairman

Resigned from the position of vice chairman and non-executive director of Cipla.

1972

Inherited Cipla

Mustafa inherited Cipla with his brother Yusuf after their father's death.

Philanthropic Impact

HealthcareUndisclosed

Cipla Foundation

Supports initiatives to improve healthcare infrastructure, medical education, and public health awareness.

Wealth Trajectory